Growth Metrics

Novartis Ag (NVS) Gross Profit (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -99.62%
Mar 31, 2023 27,234.35%
Dec 31, 2022 1,829,100.00%
Sep 30, 2022 102.94%
Jun 30, 2022 -199.95%
Mar 31, 2022 142.86%
Dec 31, 2021 -33.33%
Sep 30, 2021 250.19%
Jun 30, 2021 -199.87%
Mar 31, 2021 -99.92%
Dec 31, 2020 95,338.89%
Sep 30, 2020 -99.89%
Jun 30, 2020 9,505.65%
Mar 31, 2019 -97.61%
Dec 31, 2018 60.11%
Sep 30, 2018 -93.88%
Jun 30, 2018 55,993.75%
Mar 31, 2018 -98.05%
Dec 31, 2017 -1.32%
Sep 30, 2017 -89.91%
Jun 30, 2017 1,037.57%
Mar 31, 2017 -97.63%
Dec 31, 2016 4,441.82%
Sep 30, 2016 -7.05%
Jun 30, 2016 108,395,702.10%
Mar 31, 2016 -100.00%
Dec 31, 2015 134,951,456,310,579.61%
Mar 31, 2015 708.60%
Dec 31, 2014 -18.42%
Sep 30, 2012 -9.08%
Jun 30, 2012 0.00%
Mar 31, 2012 53.77%
Dec 31, 2011 -18.77%
Sep 30, 2011 -2.04%
Jun 30, 2011 2.76%
Mar 31, 2011 1.74%
Dec 31, 2010 1.49%
Sep 30, 2010 -19.52%
Jun 30, 2010 -90.10%
Mar 31, 2010 27,410,135.92%
Dec 31, 2009 -100.00%
Sep 30, 2009 3.40%
Jun 30, 2009 7.86%